European Commission approved Epidyolex of GW Pharmaceuticals Plc (NASDAQ:GWPH) to cure seizures associated with TSC patients aged two years and above. GW Pharmaceuticals will use EC approval for the expanded introduction of Epidyolex in Europe. EC approved EPIDYOLEX...
